| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are statins to be STASHed in subarachnoid haemorrhage?
|
Macdonald, R Loch
|
|
2014
|
13 |
7 |
p. 639-641
3 p.
|
artikel
|
| 2 |
Baló's concentric sclerosis
|
Hardy, Todd A
|
|
2014
|
13 |
7 |
p. 740-746
7 p.
|
artikel
|
| 3 |
Corrections
|
|
|
2014
|
13 |
7 |
p. 644-
1 p.
|
artikel
|
| 4 |
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
|
Boxer, Adam L
|
|
2014
|
13 |
7 |
p. 676-685
10 p.
|
artikel
|
| 5 |
Evidence or clinical implementation: which should come first?
|
Bloem, Bastiaan R
|
|
2014
|
13 |
7 |
p. 649-
1 p.
|
artikel
|
| 6 |
Frontotemporal dementia and its subtypes: a genome-wide association study
|
Ferrari, Raffaele
|
|
2014
|
13 |
7 |
p. 686-699
14 p.
|
artikel
|
| 7 |
Genome-wide association study in FTD: divide to conquer
|
Girard, Simon L
|
|
2014
|
13 |
7 |
p. 643-644
2 p.
|
artikel
|
| 8 |
Interferon beta-1a for multiple sclerosis: old drug, new clothes
|
Hartung, Hans-Peter
|
|
2014
|
13 |
7 |
p. 638-639
2 p.
|
artikel
|
| 9 |
Malformations of cortical development: clinical features and genetic causes
|
Guerrini, Renzo
|
|
2014
|
13 |
7 |
p. 710-726
17 p.
|
artikel
|
| 10 |
Multiple sclerosis genetics
|
Sawcer, Stephen
|
|
2014
|
13 |
7 |
p. 700-709
10 p.
|
artikel
|
| 11 |
Neurodevelopmental toxicity: still more questions than answers
|
Wendroff, Arnold P
|
|
2014
|
13 |
7 |
p. 646-647
2 p.
|
artikel
|
| 12 |
Neurodevelopmental toxicity: still more questions than answers
|
Feldman, Virginia
|
|
2014
|
13 |
7 |
p. 645-646
2 p.
|
artikel
|
| 13 |
Neurodevelopmental toxicity: still more questions than answers
|
Gelinas, Julianna
|
|
2014
|
13 |
7 |
p. 647-648
2 p.
|
artikel
|
| 14 |
Neurodevelopmental toxicity: still more questions than answers
|
Goldstein, Daniel A
|
|
2014
|
13 |
7 |
p. 645-
1 p.
|
artikel
|
| 15 |
Neurodevelopmental toxicity: still more questions than answers – Authors' response
|
Grandjean, Philippe
|
|
2014
|
13 |
7 |
p. 648-649
2 p.
|
artikel
|
| 16 |
News in brief
|
|
|
2014
|
13 |
7 |
p. 656-
1 p.
|
artikel
|
| 17 |
Nicole Wolf
|
|
|
2014
|
13 |
7 |
p. 653-
1 p.
|
artikel
|
| 18 |
Occasional seizures, epilepsy, and inborn errors of metabolism
|
Dulac, Olivier
|
|
2014
|
13 |
7 |
p. 727-739
13 p.
|
artikel
|
| 19 |
On thin ice
|
Goodrick, Steven
|
|
2014
|
13 |
7 |
p. 655-
1 p.
|
artikel
|
| 20 |
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
|
Calabresi, Peter A
|
|
2014
|
13 |
7 |
p. 657-665
9 p.
|
artikel
|
| 21 |
Polio-like disease in the news: much ado about nothing?
|
Mohammadi, Dara
|
|
2014
|
13 |
7 |
p. 650-651
2 p.
|
artikel
|
| 22 |
Preventing polio
|
Goodrick, Steven
|
|
2014
|
13 |
7 |
p. 653-
1 p.
|
artikel
|
| 23 |
Renzo Guerrini: seeing things other people don't see
|
Burton, Adrian
|
|
2014
|
13 |
7 |
p. 652-
1 p.
|
artikel
|
| 24 |
Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial
|
Kirkpatrick, Peter J
|
|
2014
|
13 |
7 |
p. 666-675
10 p.
|
artikel
|
| 25 |
The EAN: a new hope for European integration
|
The Lancet Neurology,
|
|
2014
|
13 |
7 |
p. 637-
1 p.
|
artikel
|
| 26 |
What Henry taught us
|
Dehnel, Tim
|
|
2014
|
13 |
7 |
p. 654-
1 p.
|
artikel
|
| 27 |
When should neuroprotective drugs move from mice to men?
|
Tariot, Pierre N
|
|
2014
|
13 |
7 |
p. 641-643
3 p.
|
artikel
|
Tijdschrift beschrijving